Effects of Anamorelin on Cancer-Related-Fatigue in Patients With Advanced Cancer
Phase of Trial: Phase II
Latest Information Update: 06 Oct 2017
At a glance
- Drugs Anamorelin (Primary)
- Indications Cancer; Fatigue; Solid tumours
- Focus Therapeutic Use
- 08 Feb 2017 Planned End Date changed from 1 May 2019 to 1 Feb 2019.
- 08 Feb 2017 Planned primary completion date changed from 1 May 2019 to 1 Feb 2019.
- 08 Feb 2017 Status changed from not yet recruiting to recruiting.